上海谊众 (688091)
Shanghai Yizhong Pharmaceutical Co., Ltd.
K-Line Chart
No K-line data available
Company NameShanghai Yizhong Pharmaceutical Co., Ltd.
Listing Date2021-09-09
Issue Price38.1RMB
Registered Capital20670.36410k RMB
Legal RepresentativeZhou Jinsong
Registered AddressNo. 79 Renqi Road, Fengxian District, Shanghai
IndustryChemical Pharmaceuticals
Main BusinessDedicated to the research, development, and industrialization of improved new anti-tumor drugs. The company possesses high-tech talents with backgrounds in polymer materials, pharmaceutical formulations, and biology, mastering core key technologies for the synthesis of nanodrug carriers and pharmaceutical polymer excipients, and demonstrating unique innovation in the field of nano-drug delivery systems.
Company ProfileShanghai Yizhong Pharmaceutical Co., Ltd. (referred to as Shanghai Yizhong) was founded in 2009. Its predecessor was Shanghai Yizhong Biotechnology Co., Ltd., located in the Oriental Beauty Valley Biotech Park in Fengxian District, Shanghai. The company is dedicated to the development of new dosage forms for anti-tumor drugs and related products, and is a high-tech pharmaceutical enterprise integrating R&D, production, and sales.
Shanghai Yizhong currently has a high-quality R&D team with professional backgrounds in pharmaceutical formulation, pharmaceutical analysis, polymer material synthesis, etc., and possesses advanced production equipment and inspection instruments compliant with GMP standards. The company is a domestic pioneer in improved new drug innovation, possessing core key technologies for nanotechnology and the preparation of pharmaceutical polymer excipients, with unique innovation in nano-drug delivery systems. It can use pharmaceutical excipients of different molecular weights through this technology to improve the dosage forms of classic drugs for clinical application, significantly enhancing their safety and efficacy, and endowing them with new value and vitality.
Stock Details
1. Key Indicators
- Total Shares(W): 734059.07
- Circulating A-Shares(W): 734059.07
- Earnings Per Share(RMB): 1.23
- Net Assets Per Share(RMB): 5.67
- Operating Revenue(W RMB): 1345261.60
- Total Profit(W RMB): 1345261.60
- **Net Profit Attributable to Parent(W RMB) **: 1345261.60
- Net Profit Growth Rate(%): -55.89
- Weighted Return on Equity(%): 4.6500
- Operating Cash Flow Per Share(RMB): 1.23
- Undistributed Profit Per Share(RMB): 1.23
- Capital Reserve Per Share(RMB): 1.23
2. Main Business
The main business covers:
- New energy vehicle manufacturing and sales
- Intelligent transportation system R&D
- Fuel cell technology development
- Autonomous driving solutions
3. Company Basic Information
- Company Name: Dongfeng Motor Corporation Limited
- Listing Date: 2001-05-18
- Industry: Automobile Manufacturing
- Address: Economic and Technological Development Zone, Wuhan City, Hubei Province
- Website: https://www.dongfeng.com.cn/
- Company Profile: The company was established with Beijing Capital Venture Group as the main sponsor. It is an enterprise focusing on automobile manufacturing and related technologies, committed to innovation and development in the fields of new energy vehicles and intelligent transportation.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | China Securities Finance Co., Ltd. | National Team | 5,000 | 10.2 |
| 2 | China Asset Management Co., Ltd. | Public Fund | 3,200 | 6.5 |
| 3 | Hillhouse Capital | Private Equity Fund | 2,800 | 5.7 |
| 4 | National Social Security Fund | National Team | 2,500 | 5.1 |
| 5 | E Fund Management Co., Ltd. | Public Fund | 2,000 | 4.1 |
| 6 | China Universal Asset Management Co., Ltd. | Public Fund | 1,800 | 3.7 |
| 7 | CITIC Securities | Broker | 1,500 | 3.1 |
| 8 | Guotai Junan Securities | Broker | 1,200 | 2.4 |
| 9 | China Merchants Bank | Bank | 1,000 | 2.0 |
| 10 | ICBC Credit Suisse Asset Management Co., Ltd. | Public Fund | 900 | 1.8 |
5. Concept Sectors
- Carbon Neutrality
- Intelligent Transportation
- Fuel Cell
- Autonomous Driving
- New Energy Vehicles
- Hydrogen Energy
- Huawei Auto
- Internet of Vehicles
Remarks
- Data update date: 2025-11-02
- Data source: Public market information